{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:46:09Z","timestamp":1791276369469,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":518,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K010514\/1"],"award-info":[{"award-number":["MR\/K010514\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Acetaminophen-induced acute liver failure (AALF) is characterized both by activation of innate immune responses and susceptibility to sepsis. Circulating monocytes and hepatic macrophages are central mediators of inflammatory responses and tissue repair processes during human AALF. Secretory leukocyte protease inhibitor (SLPI) modulates monocyte\/macrophage function through inhibition of nuclear factor kappa B (NF-\u03baB) signaling. The aims of this study were to establish the role of SLPI in AALF. Circulating levels of SLPI, monocyte cluster of differentiation 163 (CD163), human leukocyte antigen-DR (HLA-DR), and lipopolysaccharide (LPS)-stimulated levels of NF-\u03baBp65, tumor necrosis factor alpha (TNF-\u03b1) and interleukin (IL)-6 were determined in patients with AALF, chronic liver disease, and healthy controls. Immunohistochemistry and multispectral imaging of AALF explant tissue determined the cellular sources of SLPI and hepatic macrophage phenotype. The phenotype and function of monocytes and macrophages was determined following culture with recombinant human (rh)-SLPI, liver homogenates, and plasma derived from AALF patients in the presence and absence of antihuman (\u03b1)SLPI. Hepatic and circulatory concentrations of SLPI were elevated in AALF and immunohistochemistry revealed SLPI expression in biliary epithelial cells and within hepatic macrophages (h-m\u03c8) in areas of necrosis. H-m\u03c8 and circulating monocytes in AALF exhibited an anti-inflammatory phenotype and functional characteristics; typified by reductions in NF-\u03baBp65, TNF-\u03b1, and IL-6 and preserved IL-10 secretion following LPS challenge. Culture of healthy monocytes with AALF liver homogenates, plasma, or rhSLPI induced monocytes with strikingly similar anti-inflammatory characteristics which were reversed by inhibiting the activity of SLPI. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: SLPI is a pivotal mediator of anti-inflammatory responses in AALF through modulation of monocyte\/macrophage function, which may account for the susceptibility to sepsis in AALF. (HEPATOLOGY 2014;59:1564-1576)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26933","type":"journal-article","created":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T09:36:05Z","timestamp":1385544965000},"page":"1564-1576","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":91,"title":["Secretory leukocyte protease inhibitor: A pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure"],"prefix":"10.1097","volume":"59","author":[{"given":"Charalambos Gustav","family":"Antoniades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Khamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin D.","family":"Abeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie S.","family":"Taams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia A.","family":"Possamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bernsmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragai R.","family":"Mitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayel","family":"Jassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Thursz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-40-20250207","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/hep.21240","article-title":"Reduced monocyte HLADR expression: a novel biomarker of disease severity and outcome in acetaminopheninduced acute liver failure.","volume":"44","author":"Antoniades","year":"2006","journal-title":"Hepatology"},{"key":"R2-40-20250207","doi-asserted-by":"crossref","first-page":"845861","DOI":"10.1016\/j.jhep.2008.08.009","article-title":"The importance of immune dysfunction in determining outcome in acute liver failure.","volume":"49","author":"Antoniades","year":"2008","journal-title":"J Hepatol"},{"key":"R3-40-20250207","doi-asserted-by":"crossref","first-page":"13901396","DOI":"10.1007\/s00134-009-1472-x","article-title":"Predictors of bacteraemia and mortality in patients with acute liver failure.","volume":"35","author":"Karvellas","year":"2009","journal-title":"Intensive Care Med"},{"key":"R4-40-20250207","doi-asserted-by":"crossref","first-page":"734739","DOI":"10.1053\/jhep.2000.17687","article-title":"The systemic inflammatory response syndrome in acute liver failure.","volume":"32","author":"Rolando","year":"2000","journal-title":"Hepatology"},{"key":"R5-40-20250207","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1042\/CS20050115","article-title":"SLPI and elafin: one glove, many fingers.","volume":"110","author":"Williams","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"R6-40-20250207","doi-asserted-by":"crossref","first-page":"364370","DOI":"10.1165\/ajrcmb.23.3.3942","article-title":"Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts.","volume":"23","author":"Kikuchi","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R7-40-20250207","first-page":"2999930009","article-title":"Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growthassociated genes.","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"R8-40-20250207","doi-asserted-by":"crossref","first-page":"11471153","DOI":"10.1038\/80489","article-title":"Secretory leukocyte protease inhibitor mediates nonredundant functions necessary for normal wound healing.","volume":"6","author":"Ashcroft","year":"2000","journal-title":"Nat Med"},{"key":"R9-40-20250207","doi-asserted-by":"crossref","first-page":"15071514","DOI":"10.4049\/jimmunol.171.3.1507","article-title":"Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response.","volume":"171","author":"Odaka","year":"2003","journal-title":"J Immunol"},{"key":"R10-40-20250207","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/S1043-4666(02)00485-4","article-title":"Effects of secretory leukocyte protease inhibitor on the tumor necrosis factoralpha production and NFkappaB activation of lipopolysaccharidestimulated macrophages.","volume":"21","author":"Sano","year":"2003","journal-title":"Cytokine"},{"key":"R11-40-20250207","first-page":"7785","article-title":"Effects of secretory leucocyte protease inhibitor on the production of the antiinflammatory cytokines, IL10 and transforming growth factorbeta (TGFbeta), by lipopolysaccharidestimulated macrophages.","volume":"121","author":"Sano","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"R12-40-20250207","doi-asserted-by":"crossref","first-page":"605613","DOI":"10.1046\/j.1469-0691.2003.00582.x","article-title":"Plasma secretory leukocyte protease inhibitor in febrile patients.","volume":"9","author":"Duits","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"R13-40-20250207","doi-asserted-by":"crossref","first-page":"12761282","DOI":"10.1097\/00003246-200005000-00003","article-title":"Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.","volume":"28","author":"Grobmyer","year":"2000","journal-title":"Crit Care Med"},{"key":"R14-40-20250207","doi-asserted-by":"crossref","first-page":"669674","DOI":"10.1084\/jem.20021824","article-title":"Increased susceptibility to LPSinduced endotoxin shock in secretory leukoprotease inhibitor (SLPI)deficient mice.","volume":"197","author":"Nakamura","year":"2003","journal-title":"J Exp Med"},{"key":"R15-40-20250207","doi-asserted-by":"crossref","first-page":"12451252","DOI":"10.1016\/S0002-9440(10)64995-4","article-title":"Exaggerated hepatic injury due to acetaminophen challenge in mice lacking CC chemokine receptor 2.","volume":"156","author":"Hogaboam","year":"2000","journal-title":"Am J Pathol"},{"key":"R16-40-20250207","doi-asserted-by":"crossref","first-page":"14101421","DOI":"10.1189\/jlb.0308173","article-title":"Identification and characterization of infiltrating macrophages in acetaminopheninduced liver injury.","volume":"84","author":"Holt","year":"2008","journal-title":"J Leukoc Biol"},{"key":"R17-40-20250207","doi-asserted-by":"crossref","first-page":"186195","DOI":"10.1002\/hep.510300104","article-title":"Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species.","volume":"30","author":"Michael","year":"1999","journal-title":"Hepatology"},{"key":"R18-40-20250207","doi-asserted-by":"crossref","first-page":"10931103","DOI":"10.1053\/jhep.2002.33162","article-title":"Role of CCR2 in macrophage migration into the liver during acetaminopheninduced hepatotoxicity in the mouse.","volume":"35","author":"Dambach","year":"2002","journal-title":"Hepatology"},{"key":"R19-40-20250207","doi-asserted-by":"crossref","first-page":"735746","DOI":"10.1002\/hep.25657","article-title":"Source and characterization of hepatic macrophages in acetaminopheninduced acute liver failure in humans.","volume":"56","author":"Antoniades","year":"2012","journal-title":"Hepatology"},{"key":"R20-40-20250207","first-page":"823834","article-title":"CD14, CD16 and HLADR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLADR expression by CD14(hi) CD16(neg) monocytes: expansion of CD14(hi)CD16(pos) and contraction of CD14(lo)CD16(pos) monocytes in acute liver failure.","volume":"81","author":"Abeles","year":"2012","journal-title":"Cytometry A"},{"key":"R21-40-20250207","doi-asserted-by":"crossref","first-page":"558563","DOI":"10.1016\/S0140-6736(02)07743-7","article-title":"Blood lactate as an early predictor of outcome in paracetamolinduced acute liver failure: a cohort study.","volume":"359","author":"Bernal","year":"2002","journal-title":"Lancet"},{"key":"R22-40-20250207","doi-asserted-by":"crossref","first-page":"335344","DOI":"10.1002\/path.1298","article-title":"Early upregulation of chemokine expression in fulminant hepatic failure.","volume":"199","author":"Leifeld","year":"2003","journal-title":"J Pathol"},{"key":"RU23-40-20250207","doi-asserted-by":"crossref","first-page":"e11049","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic nonclassical CD14CD16 monocytes to inflammation and human liver fibrosis.","volume":"5","author":"Zimmermann","year":"2010","journal-title":"PLoS One"},{"key":"R24-40-20250207","doi-asserted-by":"crossref","first-page":"36843687","DOI":"10.1128\/IAI.72.6.3684-3687.2004","article-title":"Secretory leucoprotease inhibitor impairs Tolllike receptor 2 and 4mediated responses in monocytic cells.","volume":"72","author":"Greene","year":"2004","journal-title":"Infect Immun"},{"key":"R25-40-20250207","doi-asserted-by":"crossref","first-page":"16591668","DOI":"10.1084\/jem.20050768","article-title":"Secretory leucoprotease inhibitor binds to NFkappaB binding sites in monocytes and inhibits p65 binding.","volume":"202","author":"Taggart","year":"2005","journal-title":"J Exp Med"},{"key":"R26-40-20250207","doi-asserted-by":"crossref","first-page":"3364833653","DOI":"10.1074\/jbc.M203710200","article-title":"Secretory leucoprotease inhibitor prevents lipopolysaccharideinduced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.","volume":"277","author":"Taggart","year":"2002","journal-title":"J Biol Chem"},{"key":"R27-40-20250207","doi-asserted-by":"crossref","first-page":"10291036","DOI":"10.1183\/09031936.99.13510299","article-title":"Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.","volume":"13","author":"Sallenave","year":"1999","journal-title":"Eur Respir J"},{"key":"R28-40-20250207","doi-asserted-by":"crossref","first-page":"434441","DOI":"10.1111\/j.1365-2567.2011.03451.x","article-title":"Serine leucocyte proteinase inhibitortreated monocyte inhibits human CD4() lymphocyte proliferation.","volume":"133","author":"Guerrieri","year":"2011","journal-title":"Immunology"},{"key":"R29-40-20250207","doi-asserted-by":"crossref","first-page":"475487","DOI":"10.1016\/j.it.2009.07.009","article-title":"Endotoxin tolerance: new mechanisms, molecules and clinical significance.","volume":"30","author":"Biswas","year":"2009","journal-title":"Trends Immunol"},{"key":"R30-40-20250207","first-page":"18771883","article-title":"NFkappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance.","volume":"162","author":"AdibConquy","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-40-20250207","doi-asserted-by":"crossref","first-page":"44854489","DOI":"10.1128\/IAI.67.9.4485-4489.1999","article-title":"Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages.","volume":"67","author":"Ding","year":"1999","journal-title":"Infect Immun"},{"key":"R32-40-20250207","doi-asserted-by":"crossref","first-page":"787795","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas.","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"R33-40-20250207","doi-asserted-by":"crossref","first-page":"16501660","DOI":"10.1016\/j.molimm.2010.02.008","article-title":"Scavenger receptor CD163, a Jackofalltrades and potential target for celldirected therapy.","volume":"47","author":"Van Gorp","year":"2010","journal-title":"Mol Immunol"},{"key":"R34-40-20250207","doi-asserted-by":"crossref","first-page":"97103","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro and antiinflammatory stimuli.","volume":"67","author":"Buechler","year":"2000","journal-title":"J Leukoc Biol"},{"key":"R35-40-20250207","doi-asserted-by":"crossref","first-page":"196206","DOI":"10.1016\/j.jim.2011.10.013","article-title":"Systematic validation of specific phenotypic markers for in vitro polarized human macrophages.","volume":"375","author":"Ambarus","year":"2012","journal-title":"J Immunol Methods"},{"key":"R36-40-20250207","first-page":"295304","article-title":"A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the downregulatory phase of the inflammatory process.","volume":"55","author":"Zwadlo","year":"1987","journal-title":"Exp Cell Biol"},{"key":"R37-40-20250207","doi-asserted-by":"crossref","first-page":"24472452","DOI":"10.1128\/IAI.66.6.2447-2452.1998","article-title":"Lipopolysacchariderelated stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophagederived lipopolysaccharide inhibitor.","volume":"66","author":"Jin","year":"1998","journal-title":"Infect Immun"},{"key":"R38-40-20250207","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1111\/j.1524-475X.2011.00748.x","article-title":"Tumor necrosis factoralpha (TNFalpha) is a therapeutic target for impaired cutaneous wound healing.","volume":"20","author":"Ashcroft","year":"2012","journal-title":"Wound Repair Regen"},{"key":"R39-40-20250207","doi-asserted-by":"crossref","first-page":"317323","DOI":"10.1152\/jappl.1992.73.1.317","article-title":"Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.","volume":"73","author":"Birrer","year":"1992","journal-title":"J Appl Physiol"},{"key":"R40-40-20250207","doi-asserted-by":"crossref","first-page":"10561060","DOI":"10.1164\/ajrccm\/148.4_Pt_1.1056","article-title":"Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.","volume":"148","author":"McElvaney","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R41-40-20250207","doi-asserted-by":"crossref","first-page":"18431848","DOI":"10.1152\/jappl.1990.69.5.1843","article-title":"Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.","volume":"69","author":"Vogelmeier","year":"1990","journal-title":"J Appl Physiol"},{"key":"R42-40-20250207","doi-asserted-by":"crossref","first-page":"261S266S","DOI":"10.1378\/chest.110.6_Supplement.261S","article-title":"Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.","volume":"110","author":"Vogelmeier","year":"1996","journal-title":"Chest"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26933","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201404000-00040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:01:55Z","timestamp":1738947715000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201404000-00040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26933","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}